16-Oct-2026 | Asia Sherman

During a webinar on Thursday, U.S. Food and Drug Administration officials reiterated that updates to its generally recognized as safe (GRAS) rule would give the agency and the public a clearer picture of substances entering the food supply while preserving the legal framework that exempts qualifying GRAS uses from premarket approval as food additives.

15-Oct-2026 | Lauren Nicolle

As GLP-1 drugs reshape the weight-management landscape, supplement brands are rethinking their approach, broadening the conversation beyond weight loss to metabolic health, muscle preservation and overall wellness.

14-Oct-2026 | Asia Sherman

Swiss health sciences company Timeline secured a court order from the U.S. District Court for the District of Massachusetts targeting a network of websites that impersonated its official website, timeline.com, to sell counterfeit or non-existent Mitopure urolithin A products.

14-Oct-2026 | Nikki Hancocks

Plant cell culture (PCC) is emerging as a promising solution to some of the supplement industry’s most pressing sourcing challenges, but realizing its commercial potential will require the sector to overcome significant hurdles related to scale, investment and consumer acceptance.

14-Oct-2026 | Lauren Nicolle

A recent systematic review of randomized controlled trials raises questions about magnesium’s effectiveness as a sleep aid, concluding that the current evidence is inconsistent and of low certainty.

14-Oct-2026 | Tingmin Koe

The New Zealand government is seeking public feedback on proposed requirements for natural health products, including how health claims may be permitted and regulations for pre-market entry, manufacturing and labeling requirements.

13-Oct-2026 | Asia Sherman

Growing supplement use, novel ingredients, personalized nutrition and digital health advice are challenging safety frameworks in a fragmented global regulatory landscape, prompting greater discussion about the tools needed to foster regulatory coherence.

13-Oct-2026 | Eric Royer, Global Business Development Executive, GIRACT

For European sports nutrition companies, protein sourcing has become a more serious commercial issue. Whey prices have risen sharply, supply remains tight and manufacturers are having to think harder about where they use whey, which grade they need and where another protein can do part of the job.

13-Oct-2026 | Tingmin Koe

Brands in Australia have begun voluntarily recalling listed medicines containing andrographis following a ban issued by the Therapeutic Goods Administration (TGA) last month over concerns that the herb may trigger anaphylactic reactions.